Protagonist Therapeutics Inc (NASDAQ:PTGX) currently has a daily average trading volume of 870.72K but it saw 1310108 shares traded in last market. With a market cap of 3.36B USD, the company’s current market price of $54.19 came falling about -1.45 while comparing to the previous closing price of $54.99. In past 52 weeks, the stock remained buoying in the range of price level as high as $60.60 and as low as $32.50. In the recent trading on the day, stock has struck highest price mark of $51.5528 while lowest mark touched by it was $55.02.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the Citigroup which initiated the stock as “Buy” in its note to investors issued on June 17, 2025, recommending a price target of $72 for it. BMO Capital Markets also issued its recommendations for the stock as it initiated the price target for the stock is $62.
Over the week, PTGX’s stock price is moving -4.33% down while it is 1.56% when we observe its performance for the past one month. Year-to-date it is 52.43% up and over the past year, the stock is showing an upside performance of 40.39%.
Currently, Protagonist Therapeutics Inc’s total number of outstanding shares is 61.93M. Company’s return on investment (ROI) stands at 8.04% and return on equity (ROE) at 8.99%. It has a price to earnings ratio (P/E ratio) of 71.24. Stock’s beta reads 2.34. Stock has a price to book (P/B) ratio of 4.87 while price to sale or P/S ratio amounts to 16.16. Its return on asset (ROA) is 8.19% on average.
